Wednesday, 27 February 2019

Blackstone Life Sciences and Novartis Launch Anthos Therapeutics to Develop Innovative Medicines for Cardiovascular Disease - Odessa American

Blackstone Life Sciences and Novartis Launch Anthos Therapeutics to Develop Innovative Medicines for Cardiovascular Disease  Odessa American

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb 27, 2019--Blackstone Life Sciences today announced the launch of Anthos Therapeutics Inc. (“Anthos”), a new ...

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)